Search Results 1351-1360 of 19145 for Neutrophil

1. E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) - Mayo Clinic

   - Absolute neutrophil count (ANC) >= 1.0 x 10^9 cells/L without ongoing transfusional support (obtained =< 15 days prior to registration) - Platelets >= 75 ...

2. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   Neutrophils ≥ 1,000 mm^3; Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) and serum glutamate pyruvate transaminase (SGPT) ...

3. Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases - Mayo Clinic

   Absolute neutrophil count (ANC) of ≥ 1,500/mL within 21 days prior to registration. Hemoglobin ≥ 9 g/dL within 21 days prior to registration. Platelet ...

4. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1000/mm3 (≥1.0 × 10\^9/L) if no lymphoma infiltration of bone marrow OR ANC ≥750/mm3 (≥75 × 10\^9/L) with bone marrow ...

5. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

   Impaired hematologic function: hemoglobin < 11 g/dL; neutrophil count < 1.6 × 109/L; or platelet count < 100 × 109/L. Any laboratory screening test that ...

6. A Study to Compare Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian or Primary Peritoneal Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl (within 14 days prior to registration). Platelets greater than or equal to 100,000 cells ...

7. Sulfamethoxazole and trimethoprim (oral route) - Side effects & dosage - Mayo Clinic

   ... neutrophilic dermatosis (AFND). Check with your doctor if you have a skin rash, blistering, peeling, loosening of the skin, chills, cough, diarrhea, itching ...

8. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelets ≥ 75,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN); Note ...

9. Intrapleural Measles Virus Therapy in Patients with Malignant Pleural Mesothelioma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/μL; Platelet count ≥ 100,000/μL; Total bilirubin ≤ 1.5 x upper limit of institutional normal; Aspartate ...

10. A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    Evidence of myeloid engraftment (e.g., absolute neutrophil count ≥ 1.0 × 10^9/L for 3 consecutive days if ablative therapy was previously used). Use of ...